Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05619055

The Intestinal Dysbacteriosis in the Pathogenesis of Necrotizing Enterocolitis

Conditions: Necrotizing Enterocolitis of Newborn

Sex: All
Ages: 5 Days – 2 Months
Healthy volunteers: 1
Enrollment: 30
Sponsor: Zuohui Zhao

Location: China

Summary

Study DescriptionThe goal of this observational study is to detect intestinal flora and the metabolic products in premature infants diagnosed as necrotizing enterocolitis. The main questions it aims to answer are:1. Whether there is intestinal flora in the stool of premature infants.2. Are there dysregulated intestinal flora and their metabolic products in premature infants diagnosed as necrotizing enterocolitis.3. The detailed role and underlying mechanism of the intestinal dysbacteriosis and the metabolic products in premature infants diagnosed as necrotizing enterocolitis.Participants, premature infants diagnosed as necrotizing enterocolitis (NEC group), will be asked to collect stool (usually 2 times) for intestinal flora analysis.If there is a comparison group: Researchers will compare premature infants without necrotizing enterocolitis (control group) to see if their intestinal flora and the metabolic products also changed as their NEC counterparts.

Eligibility Criteria

Inclusion Criteria:clinical diagnosis of Necrotizing Enterocolitis,gestational age <37 weeks,body weight 1,000-2,500 g,postnatal Apgar score ≥7,initial oral feeding tolerance.Exclusion Criteria:serious hereditary or other serious diseases, such as heart, lung and abdominal malformations ,early or late onset septicemia,early use of antibiotics in the newborn,serious adverse reactions caused by probiotics.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05619055). StuddyBuddy aggregates publicly available trial information.